Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:39 PM
Ignite Modification Date:
2025-12-24 @ 6:39 PM
NCT ID:
NCT06372457
Eligibility Criteria:
Inclusion Criteria:
* Source Cohort
\- Have at least one recorded encounter with a Hypertrophic Cardiomyopathy (HCM) diagnosis during or after 2018 (the first is defined as the index) and aged ≥18 years on the index date.
\- Disease-specific patient history documented in the medical record.
* HCM Sub-Cohort
\- Participants in the source cohort with a known HCM diagnosis
* Mavacamten Sub-Cohort - Participants who have their first mavacamten prescription after the index date
Exclusion Criteria:
• HCM Sub-Cohort
\- HCM phenocopy (athlete's heart, hypertensive heart disease, Fabry disease, Pompe disease, Danon disease, amyloidosis) observed after the first observed HCM-associated encounter in the medical record.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06372457
Study Brief:
Protocol Section:
NCT06372457